A synthetic polymer, poly(2-methacryloyloxyethyl phosphorylcholine-co-n-stearyl methacrylate), stimulates insulin release from RINm5F insulinoma cells

Biosci Biotechnol Biochem. 2004 Oct;68(10):2197-200. doi: 10.1271/bbb.68.2197.

Abstract

A water-soluble phospholipid-like polymer, poly(2-methacryloyloxyethyl phosphorylcholine-co-n-stearyl methacrylate) (PMC(18), average molecular weight = 4.3 x 10(4)), at a concentration (0.5-5 mg/ml) showing no inhibition of cell proliferation, stimulated insulin release from RINm5F rat insulinoma cells in a concentration- and time-related manner. But poly(2-methacryloyloxyethyl phosphorylcholine) and other synthetic phospholipid-like polymers failed to stimulate insulin release.

MeSH terms

  • Animals
  • Cell Proliferation / drug effects
  • Exocytosis / drug effects*
  • Exocytosis / physiology
  • Insulin / metabolism*
  • Insulin Secretion
  • Insulinoma / metabolism*
  • Methacrylates / pharmacology*
  • Pancreatic Neoplasms / metabolism*
  • Phosphorylcholine / analogs & derivatives*
  • Phosphorylcholine / pharmacology*
  • Polymethacrylic Acids
  • Rats
  • Tumor Cells, Cultured

Substances

  • Insulin
  • Methacrylates
  • Polymethacrylic Acids
  • poly(2-methacryloyloxyethyl phosphorylcholine-co-n-stearyl methacrylate)
  • poly(2-methacryloyloxyethyl-phosphorylcholine)
  • Phosphorylcholine